208 related articles for article (PubMed ID: 23009584)
1. The bioinformatics analysis of miRNAs signatures differentially expressed in HER2(+) versus HER2(-) breast cancers.
Nie W; Jin L; Wang Y; Wang Z; Guan X
Cancer Biother Radiopharm; 2013 Feb; 28(1):71-6. PubMed ID: 23009584
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis of regulated MicroRNAs by placental growth factor signaling in cancer stem cells.
Salehi Z; Akrami H; Seydi H
J Cancer Res Ther; 2020 Dec; 16(Supplement):S90-S94. PubMed ID: 33380659
[TBL] [Abstract][Full Text] [Related]
3. Target genes prediction and functional analysis of microRNAs differentially expressed in gastric cancer stem cells MKN-45.
Salehi Z; Akrami H
J Cancer Res Ther; 2017; 13(3):477-483. PubMed ID: 28862212
[TBL] [Abstract][Full Text] [Related]
4. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
[TBL] [Abstract][Full Text] [Related]
5. Identification of the key pathways and genes involved in HER2-positive breast cancer with brain metastasis.
Lu X; Gao C; Liu C; Zhuang J; Su P; Li H; Wang X; Sun C
Pathol Res Pract; 2019 Aug; 215(8):152475. PubMed ID: 31178227
[TBL] [Abstract][Full Text] [Related]
6. Key Genes and Prognostic Analysis in HER2+ Breast Cancer.
Weng Y; Liang W; Ji Y; Li Z; Jia R; Liang Y; Ning P; Xu Y
Technol Cancer Res Treat; 2021; 20():1533033820983298. PubMed ID: 33499770
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer.
McDermott AM; Miller N; Wall D; Martyn LM; Ball G; Sweeney KJ; Kerin MJ
PLoS One; 2014; 9(1):e87032. PubMed ID: 24498016
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression profiling and functional annotation analysis of their targets in patients with type 1 diabetes mellitus.
Takahashi P; Xavier DJ; Evangelista AF; Manoel-Caetano FS; Macedo C; Collares CV; Foss-Freitas MC; Foss MC; Rassi DM; Donadi EA; Passos GA; Sakamoto-Hojo ET
Gene; 2014 Apr; 539(2):213-23. PubMed ID: 24530307
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics analysis of differentially expressed miRNA-related mRNAs and their prognostic value in breast carcinoma.
Zhang GM; Goyal H; Song LL
Oncol Rep; 2018 Jun; 39(6):2865-2872. PubMed ID: 29693181
[TBL] [Abstract][Full Text] [Related]
10. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
[TBL] [Abstract][Full Text] [Related]
11. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E
Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588
[TBL] [Abstract][Full Text] [Related]
12. [Exploratory screening of potential pan-cancer biomarkers based on The Cancer Genome Atlas database].
Zhou C; Ma X; Xing YK; Li LD; Chen J; Yao BY; Fu JL; Zhao P
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 53(3):602-607. PubMed ID: 34145869
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer.
Lowery AJ; Miller N; Devaney A; McNeill RE; Davoren PA; Lemetre C; Benes V; Schmidt S; Blake J; Ball G; Kerin MJ
Breast Cancer Res; 2009; 11(3):R27. PubMed ID: 19432961
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis of aggressive behavior of breast cancer via an integrated gene regulatory network.
Yang X; Jia M; Li Z; Lu S; Qi X; Zhao B; Wang X; Rong Y; Shi J; Zhang Z; Xu W; Gao Y; Zhang S; Yu G
J Cancer Res Ther; 2014; 10(4):1013-8. PubMed ID: 25579546
[TBL] [Abstract][Full Text] [Related]
15. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
Wang YW; Zhang W; Ma R
Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
[TBL] [Abstract][Full Text] [Related]
17. The Role of Significantly Deregulated MicroRNAs in Recurrent Cervical Cancer Based on Bioinformatic Analysis of the Cancer Genome Atlas Data.
Liu H; Liu L; Zhu H
J Comput Biol; 2019 Apr; 26(4):387-395. PubMed ID: 30762435
[TBL] [Abstract][Full Text] [Related]
18. Investigation of microRNA expression signatures in HCC via microRNA Gene Chip and bioinformatics analysis.
Zhou L; Zhu W; Wang G; Cao X; Zhang X; Chen Q
Pathol Res Pract; 2020 Jun; 216(6):152982. PubMed ID: 32360250
[TBL] [Abstract][Full Text] [Related]
19. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
20. Screening and bioinformatics analysis of a ceRNA network based on the circular RNAs, miRNAs, and mRNAs in pan-cancer.
Chen Z; Huang J; Feng Y; Li Z; Jiang Y
Cancer Med; 2020 Oct; 9(19):7279-7292. PubMed ID: 33094914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
